Regulation of p27Kip1 by intracellular iron levels

被引:16
|
作者
Wang, G [1 ]
Miskimins, R [1 ]
Miskimins, WK [1 ]
机构
[1] Univ S Dakota, Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA
关键词
D O I
10.1023/A:1024417309370
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enhanced intracellular iron levels are essential for proliferation of mammalian cells. If cells have entered S phase when iron is limiting, an adequate supply of deoxynucleotides cannot be maintained and the cells arrest with incompletely replicated DNA. In contrast, proliferating cells that are not in S phase, but have low iron pools, arrest in late G1. In this report the mechanism of iron-dependent G1 arrest in normal fibroblasts was investigated. Cells were synchronized in G0 by contact inhibition and serum deprivation. Addition of serum caused the cells to re-enter the cell cycle and enter S phase. However, if the cells were also treated with the iron chelator deferoxamine, S phase entry was blocked. This corresponded to elevated levels of the cyclin dependent kinase inhibitor p27(Kip1) and inhibition of CDK2 activity. Expression of other cell cycle regulatory proteins was not affected, including the induction of cyclins D1 and E. When the quiescent serum starved cells were supplemented with a readily usable form of iron in the absence of serum or any other growth factors, a significant population of the cells entered S phase. This was associated with downregulation of p27(Kip1) and increased CDK2 activity. Using an IPTG-responsive construct to artificially raise p27(Kip1) levels blocked the ability of iron supplementation to promote S phase entry. Thus it appears that p27(Kip1) is a mediator of G1 arrest in iron depleted Swiss 3T3 fibroblasts. We propose that this is part of an iron-sensitive checkpoint that functions to ensure that cells have sufficient iron pools to support DNA synthesis prior to entry into S phase.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 50 条
  • [21] Regulation of p27Kip1 by mitogen-induced tyrosine phosphorylation
    Jaekel, Heidelinde
    Peschel, Ines
    Kunze, Clarissa
    Weinl, Christina
    Hengst, Ludger
    CELL CYCLE, 2012, 11 (10) : 1910 - 1917
  • [22] How to decrease p27Kip1 levels during tumor development
    Koff, A
    CANCER CELL, 2006, 9 (02) : 75 - 76
  • [23] p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression
    Song, Wei
    Xie, Ruilian
    Zhu, Aiyu
    Xu, Yumei
    Shi, Yaqin
    Shen, Yan
    Zhang, Wenwen
    Yang, Fang
    Guan, Xiaoxiang
    ONCOTARGETS AND THERAPY, 2015, 8 : 1863 - 1869
  • [24] p27Kip1 knockout mice are protected from diabetic nephropathy:: Evidence for p27Kip1 haplotype insufficiency
    Wolf, G
    Schanze, A
    Stahl, RAK
    Shankland, SJ
    Amann, K
    KIDNEY INTERNATIONAL, 2005, 68 (04) : 1583 - 1589
  • [25] Expression of cyclin A and p27Kip1 in meningiomas
    Nakabayashi, H
    Sunada, I
    Hakuba, A
    11TH EUROPEAN CONGRESS OF NEUROSURGERY: EUROPEAN ASSOCIATION OF NEUROSURGICAL SOCIETIES (EANS), 1999, : 249 - 254
  • [26] p27Kip1:: The "rosebud" of diabetic nephropathy?
    Wolf, G
    Shankland, SJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03): : 819 - 822
  • [27] p27kip1: a target for tumor therapies?
    Nickeleit, Irina
    Zender, Steffen
    Kossatz, Uta
    Malek, Nisar P.
    CELL DIVISION, 2007, 2 (1)
  • [28] p27Kip1 metabolism - A fascinating labyrinth
    Borriello, Adriana
    Cucciolla, Valeria
    Oliva, Adriana
    Zappia, Vincenzo
    Della Ragione, Fulvio
    CELL CYCLE, 2007, 6 (09) : 1053 - 1061
  • [29] CDKI p27kip1与肿瘤
    王刚
    现代妇产科进展, 1999, (04) : 360 - 363
  • [30] p27kip1与膀胱肿瘤
    王洋
    施国伟
    何家扬
    国际泌尿系统杂志, 2005, (04) : 452 - 455